未登录

B

Brian G. Southwell

research triangle institute

H指数:36

被引数:4,872

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Social Context Considerations for Future HIV Vaccine Introduction and Implementation

未来HIV疫苗引入和实施的社会背景考量

IF3.4

2026-05-190

OAAI

Evaluating an Experiential Learning Approach to Training and Supporting Early-Stage Researchers

评估一种体验式学习方法在培训和支持早期研究人员中的应用

Education Sciences

IF2.6

2026-04-070

OAAI

Acknowledging Uncertainty and the Scientific Process Increases Perceived Trustworthiness and Understanding of Public Health Risk Communication

Journal of Public Health Management and Practice

IF1.9

2026-01-011

PRE

The Importance of Assessing Failure, Unexpected Results, and Lessons Learned for Advancing Health Communication Science

评估失败、意外结果和经验教训对于推动健康传播科学的重要性

JOURNAL OF HEALTH COMMUNICATION

IF2.4

2025-03-310

PRE

Provider communication contributes to colorectal cancer screening intention through improving screening outcome expectancies and perceived behavioral control

提供者沟通通过改善筛查结果预期和感知行为控制有助于结直肠癌筛查意图

SOCIAL SCIENCE & MEDICINE

IF5

2024-01-010

OAAI

Provider communication contributes to colorectal cancer screening intention through improving screening outcome expectancies and perceived behavioral control

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Alcohol and Cancer: Existing Knowledge and Evidence Gaps across the Cancer Continuum

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2022-01-1117

OA

News coverage about aspirin as a countervailing force against low-dose aspirin campaign promotion

TRANSLATIONAL BEHAVIORAL MEDICINE

IF3

2021-06-033

OA

Development and validation of prescription drug risk, efficacy, and benefit perception measures in the context of direct-to-consumer prescription drug advertising

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2021-05-0112

OAAI

Predictors of willingness to get a COVID-19 vaccine in the U.S (vol 21, 338, 2021)

BMC INFECTIOUS DISEASES

IF3

2021-04-269

OAAI

Experimental evidence of consumer and physician detection and rejection of misleading prescription drug website content

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2021-04-0110

PREAI

Mental Models of Infectious Diseases and Public Understanding of COVID-19 Prevention

HEALTH COMMUNICATION

IF2.7

2020-10-2122

PREAI

Roles for Health Care Professionals in Addressing Patient-Held Misinformation Beyond Fact Correction

AMERICAN JOURNAL OF PUBLIC HEALTH

IF9.6

2020-10-0128

OAAI

Social science and price transparency in direct-to-consumer prescription drug advertisements

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2020-06-012

PREAI

Misinformation as a Misunderstood Challenge to Public Health

AMERICAN JOURNAL OF PREVENTIVE MEDICINE

IF4.5

2019-08-01147

PREAI

Effects of E-cigarette Advertising Message Form and Cues on Cessation Intention: An Exploratory Study

JOURNAL OF HEALTH COMMUNICATION

IF2.4

2019-07-125

OAAI

Individual- and Ad-Level Predictors of Perceptions of Serious and Actionable Risks in Direct-to-Consumer Prescription Drug TV Advertising

JOURNAL OF HEALTH COMMUNICATION

IF2.4

2019-06-285

PREAI

Aging and Direct-to-Consumer Prescription Drug Television Ads: The Effects of Individual Differences and Risk Presentation

JOURNAL OF HEALTH COMMUNICATION

IF2.4

2019-04-239

OAAI

Conversations about pictorial cigarette pack warnings: Theoretical mechanisms of influence

关于图片香烟包装警告的对话: 影响的理论机制

SOCIAL SCIENCE & MEDICINE

IF5

2018-12-0126

OAAI

Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2018-10-0115

OAAI